Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maher

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Progress in Molecular Biology and Translational Science|August 7, 2019
Synergistic combination of oncolytic virotherapy with CAR T-cell therapyAdam Ajina, John Maher
Immunotherapy Advances|May 31, 2021
An overview of CAR T-cell clinical trial activity to 2021Antonella Adami, John Maher
Biochemical Society Transactions|April 13, 2016
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancerDaniela Achkova, John Maher
Journal for Immunotherapy of Cancer|November 22, 2017
Prospects for combined use of oncolytic viruses and CAR T-cellsAdam Ajina, John Maher
Expert Opinion on Biological Therapy|November 27, 2020
Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy - what are we doing; where are we going?Natasha Bechman, John Maher
Cancer Research|June 3, 2009
CAR mechanics: driving T cells into the MUC of cancerJohn Maher, Scott Wilkie
Translational Cancer Research|February 12, 2026
Therapeutic application of IL-12 for cancer therapyZhiqing Qi, John Maher
Molecular Oncology|November 14, 2015
CAR T-cell immunotherapy: The path from the by-road to the freeway?Lynsey M Whilding, John Maher
Expert Opinion on Drug Discovery|May 26, 2021
Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignanciesCaroline M Hull, John Maher
Biology|February 25, 2023
CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target AntigensJohn Maher, David M Davies
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Progress in Molecular Biology and Translational Science|August 7, 2019
Synergistic combination of oncolytic virotherapy with CAR T-cell therapyAdam Ajina, John Maher
Immunotherapy Advances|May 31, 2021
An overview of CAR T-cell clinical trial activity to 2021Antonella Adami, John Maher
Biochemical Society Transactions|April 13, 2016
Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancerDaniela Achkova, John Maher
Journal for Immunotherapy of Cancer|November 22, 2017
Prospects for combined use of oncolytic viruses and CAR T-cellsAdam Ajina, John Maher
Expert Opinion on Biological Therapy|November 27, 2020
Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy - what are we doing; where are we going?Natasha Bechman, John Maher
Cancer Research|June 3, 2009
CAR mechanics: driving T cells into the MUC of cancerJohn Maher, Scott Wilkie
Translational Cancer Research|February 12, 2026
Therapeutic application of IL-12 for cancer therapyZhiqing Qi, John Maher
Molecular Oncology|November 14, 2015
CAR T-cell immunotherapy: The path from the by-road to the freeway?Lynsey M Whilding, John Maher
Expert Opinion on Drug Discovery|May 26, 2021
Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignanciesCaroline M Hull, John Maher
Biology|February 25, 2023
CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target AntigensJohn Maher, David M Davies
Pageof 14